FDA Extends Review of Opzelura for Pediatric Atopic Dermatitis
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.
Guidepoint Qsight’s Erik Haines breaks down the drivers behind 2024’s $17.5 billion in non-surgical aesthetic spending and what it signals for the future of the industry.
A new ISAPS report shows a facial procedure has overtaken liposuction as the most-performed surgery worldwide.
A new report examines the key drivers, growth opportunities, and challenges shaping the hyaluronic acid dermal fillers market.
While known for cosmetic procedures, Raghu Athré also provides reconstructive care to patients facing medical and financial hardship.